Impact Of RA Therapy Compliance On Patient-Reported Outcomes



Status:Completed
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:11/18/2012
Start Date:October 2011
End Date:December 2012
Contact:Pfizer CT.gov Call Center
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Several observational studies have evaluated the comparative treatment costs associated with
each agent, particularly those within the anti-TNF class, but few have evaluated the impact
of therapy compliance, persistence, treatment patterns on patient reported outcomes,
healthcare utilization and costs, using a provider database. This study is designed to fill
in this information gap.


Cohort observational

Inclusion Criteria:

Adults with moderate to severe RA who are currently using a DMARD

Exclusion Criteria:

Psoriatic Arthritis (PsA), Psoriasis (PsO), SSystemic Lupus Erythematosus (SLE),
Non-Disease modifying anti-rheumatic disease (non-DMARD) use
We found this trial at
1
site
Pfizer Investigational Site
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials